AstraZeneca aims for a full listing in New York, but remains headquartered in the United Kingdom.
Adrian Rusu
International
Foto: shutterstock.com/ro
Always see our news on Google
AstraZeneca announced on Monday that it intends to move to a direct listing of its shares on the New York Stock Exchange, in a move aimed at capitalizing on the high appetite of American investors, but emphasized that it will not leave London.
Sources
Gigantul farmaceutic european AstraZeneca vizează listare completă la New York
AstraZeneca vizează listare completă la New York, dar îşi reafirmă angajamentul faţă de Londra
UK plc can't afford to lose AstraZeneca to Wall Street
AstraZeneca's listing rejig spells long-term danger for London | Nils Pratley
AstraZeneca trece la listare directă pe bursa din New York, dar rămâne cu sediul în Marea Britanie
Latest News
12:21
The Greens are calling for a European plan to address heatwaves, with protection for buildings and workers and a timetable for phasing out fossil fuels
12:14
George Simion mocks Nicușor Dan: “We are dealing with a bungler”
12:10
Diesel prices rise / Price reaches 10.64 lei per liter at Petrom
12:05
Nicușor Dan Calls Parties to Cotroceni for Consultations on the Nomination of the Prime Minister
12:03
The Commission proposes faster recognition of qualifications for work in another EU country and compensation for delays
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
IT&C knowledge
OpenAI abandons plans to go public in 2026 / Sam Altman: “It would be an inappropriate time”
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
